Non-steroid, Atopic Dermatitis Phase IIb 12-week Trial; Topical WBI-1001 Cream

Clinical trial NCT01098734 · COMPLETED

Trial details

NCT number: NCT01098734
Sponsor: Welichem Biotech Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Dermatitis, Atopic

Start date: 2009-11-01
Primary completion: 2010-10-01
Enrollment: 148

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.